Skip to main content
NCBI home page
Current Therapeutic Research, Clinical and Experimental logoLink to Current Therapeutic Research, Clinical and Experimental
. 2008 Oct;69(5):449–458. doi: 10.1016/j.curtheres.2008.10.001

Effects of nebivolol on skin flap survival: A randomized experimental study in rats

Kaan Gideroglu 1,a, Sahin Alagoz 2, Fatih Uygur 3, Rahmi Evinc 3, Bahattin Celikoz 3, Guler Bugdayci 4
PMCID: PMC3969915  PMID: 24692819

Abstract

Background: Skin flaps are among the basic treatment options in the reconstruction of soft tissue defects. To improve skin flap survival, a variety of methods, including pharmacologic agents, have been investigated. The effectiveness of anticoagulants, antioxidants, anti-inflammatory drugs, and vasodilatory drugs in improving flap survival has been studied. Nebivolol is a new-generation selective β1-adrenoreceptor blocking agent that has vasodilatory, antithrombotic, antioxidative, and anti- inflammatory effects.

Objective: The aim of this experimental study was to investigate the effects of nebivolol (50 mg/kg/d) on random pattern skin flap survival in rats.

Methods: Male Wistar rats weighing 290 to 310 g were randomly divided into 2 groups—the nebivolol group and the control group. Random patterned, caudally-based, ~3 × 10-cm skin flaps were elevated on the back of each rat. In the nebivolol group, nebivolol 50 mg/kg/d (1 mL, of a racemic solution of nebivolol) was administered orally 2 days before surgery to reach steady-state drug blood concentrations and was continued for 6 days. In the control group, 1 mL/d of sterile saline solution was orally administered 2 days before surgery and was continued for 6 days. To observe the effects of nebivolol, cutaneous blood flow was examined using a laser Doppler flow-meter before and after surgery on days 1, 3, 5, and 7, and flap tissue, malondialdehyde (MDA) and glutathione (GSH) concentrations, and superoxide dismutase (SOD) activity were measured 7 days postsurgery. Flap viability was evaluated 7 days after surgery by measuring necrotic flap area and total flap area.

Results: All 20 rats (nebivolol group, n = 10; control group, n = 10) survived throughout the study period. Mean (SD) MDA concentration was significantly lower in the nebivolol group than in the control group (69.25 [5.82] vs 77.67 [6.87] nmol/g tissue; P = 0.009). GSH concentration was significantly higher in the nebivolol group than in the control group (2.14 [0.15] vs 1.88 [0.22] nmol/mg tissue; P = 0.004). SOD activity was significantly greater in the nebivolol group than in the control group (49.28 [5.49] vs 42.09 [4.95] U/g tissue; P = 0.007). The percentage of the flap that was necrotic was significantly lower in the nebivolol group than in the control group (40.27 [4.08] vs 48.87 [6.35]; P = 0.007).

Conclusions: This small, experimental, in vivo animal study found that nebivolol was associated with reduced necrotic random pattern skin flap area. Further studies are needed to clarify these findings.

Key Words: nebivolol, skin flap survival, cutaneous blood flow

Full Text

The Full Text of this article is available as a PDF (868.0 KB).

References

  • 1.Törkvist L, Löfberg R, Raud J, Thorlacius H. Heparin protects against skin flap necrosis: Relationship to neutrophil recruitment and anti-coagulant activity. Inflamm Res. 2004;53:1–3. doi: 10.1007/s00011-003-1218-0. [DOI] [PubMed] [Google Scholar]
  • 2.Akan M, Cakir B, Misirlioglû A. Effects of clopidogrel and high dose aspirin on survival of skin flaps in rats. Scand J Plast Reconstr Surg Hand Surg. 2005;39:7–10. doi: 10.1080/02844310410017951. [DOI] [PubMed] [Google Scholar]
  • 3.Cetin C, Köse AA, Aral E. Protective effect of fucoidin (a neutrophil rolling inhibitor) on ischemia reperfusion injury: Experimental study in rat epigastric island flaps. Ann Plast surg. 2001;47:540–546. doi: 10.1097/00000637-200111000-00012. [DOI] [PubMed] [Google Scholar]
  • 4.Gute DC, Ishida T, Yarimizu K, Korthuis RJ. Inflammatory responses to ischemia and reperfusion in skeletal muscle. Mol Cell Biochem. 1998;179:169–187. doi: 10.1023/a:1006832207864. [DOI] [PubMed] [Google Scholar]
  • 5.Lee C, Kerrigan CL, Tellado JM. Altered neutrophil function following reperfusion of an ischemic myocutaneous flap. Plast Reconstr Surg. 1992;89:916–923. doi: 10.1097/00006534-199205000-00023. [DOI] [PubMed] [Google Scholar]
  • 6.Bilen BT, Kilinç H, Alaybeyoglu N. Effect of caffeic acid phenethyl ester on survival of axial pattern flaps in rats with ischemia-reperfusion injuries. Scand J Plast Reconstr Surg Hand Surg. 2006;40:73–78. doi: 10.1080/02844310500443030. [DOI] [PubMed] [Google Scholar]
  • 7.Aust SD, Thomas CE, Morehouse LA. Active oxygen and toxicity. Adv Exp Med Biol. 1986;197:513–526. doi: 10.1007/978-1-4684-5134-4_49. [DOI] [PubMed] [Google Scholar]
  • 8.Ozyurt H, Irmak MK, Akyol O, Söğüt S. Caffeic acid phenethyl ester changes the indices of oxidative stress in serum of rats with renal ischaemia-reperfusion injury. Cell Biochem Funct. 2001;19:259–263. doi: 10.1002/cbf.923. [DOI] [PubMed] [Google Scholar]
  • 9.Akamatsu J, Ueda K, Tajima S, Nozawa M. Sulfatide elongates dorsal skin flap survival in rats. J Surg Res. 2000;92:36–39. doi: 10.1006/jsre.2000.5819. [DOI] [PubMed] [Google Scholar]
  • 10.Aydogan H, Gurlek A, Parlakpinar H. Beneficial effects of caffeic acid phenethyl ester (CAPE) on the ischaemia-reperfusion injury in rat skin flaps. J Plast Reconstr Aesthet Surg. 2007;60:563–568. doi: 10.1016/j.bjps.2006.01.030. [DOI] [PubMed] [Google Scholar]
  • 11.Suzuki S, Miyachi Y, Niwa Y, Issihiki N. Significance of reactive oxygen species in distal flap necrosis and its salvage with liposomal SOD. Br J Plast Surg. 1989;42:559–564. doi: 10.1016/0007-1226(89)90045-3. [DOI] [PubMed] [Google Scholar]
  • 12.Gurlek A, Celik M, Parlakpinar H. The protective effect of melatonin on ischemia-reperfusion injury in the groin (inferior epigastric) flap model in rats. J Pineal Res. 2006;40:312–317. doi: 10.1111/j.1600-079X.2006.00319.x. [DOI] [PubMed] [Google Scholar]
  • 13.Canbaz H, Akca T, Tataroglu C. The effects of exogenous L-carnitine on lipid peroxidation and tissue damage in an experimental warm hepatic ischemia-reperfusion injury model. Curr Ther Res Clin Exp. 2007;68:32–46. doi: 10.1016/j.curtheres.2007.02.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Tellioglŭ AT, Uras KA, Ylmaz T. The effect of carnitine on random-pattern flap survival in rats. Plast Reconstr Surg. 2001;108:959–962. doi: 10.1097/00006534-200109150-00021. [DOI] [PubMed] [Google Scholar]
  • 15.Erçöçn AR, Apaydin I, Emiroglŭ M. The effects of L-arginine and iloprost on the viability of random skin flaps in rats. Scand J Plast Reconstr Surg Hand Surg. 1998;32:19–25. doi: 10.1080/02844319850158912. [DOI] [PubMed] [Google Scholar]
  • 16.Atabey A, Im MJ, Akgur FM. The effect of cobalt chloride on skin flap survival. Br J Plast Surg. 1996;49:321–324. doi: 10.1016/s0007-1226(96)90164-2. [DOI] [PubMed] [Google Scholar]
  • 17.Yücel A, Bayramiçli M. Effects of hyperbaric oxygen treatment and heparin on the survival of unipedicled venous flaps: An experimental study in rats. Ann Plast Surg. 2000;44:295–303. doi: 10.1097/00000637-200044030-00008. [DOI] [PubMed] [Google Scholar]
  • 18.Türegün M, Nisanci M, Duman H, Selmanpakoglŭ N. The effects of nitric oxide usage on microcircutation of muscle flaps in ischemia-reperfusion injury [in Turkish] Turkish Plast Recons Surg. 1999;7:49–54. [Google Scholar]
  • 19.Zhang F, Yang F, Hu EC. Vascular endothelial growth factor gene therapy in improvement of skin paddle survival in a rat TRAM flap model. J Reconstr Microsurg. 2005;21:391–396. doi: 10.1055/s-2005-915207. [DOI] [PubMed] [Google Scholar]
  • 20.Sud V, Lindley SG, McDaniel O. Evaluation of fructose 1,6 diphosphate for salvage of ischemic gracilis flaps in rats. J Reconstr Microsurg. 2005;21:191–196. doi: 10.1055/s-2005-869826. [DOI] [PubMed] [Google Scholar]
  • 21.Ilhan A, Yilmaz HR, Armutcu F. The protective effect of nebivolol on ischemia/reperfusion injury in rabbit spinal cord. Prog Neuropsychopharmacol Biol Psychiatry. 2004;28:1153–1160. doi: 10.1016/j.pnpbp.2004.06.023. [DOI] [PubMed] [Google Scholar]
  • 22.Mangrella M, Rossi F, Fici F, Rossi F. Pharmacology of nebivolol. Pharmacol Res. 1998;8:419–431. doi: 10.1006/phrs.1998.0387. [DOI] [PubMed] [Google Scholar]
  • 23.Kubli S, Feihl F, Waeber B. Beta-blockade with nebivolol enhances the acetylcholine-induced cutaneous vasodilation. Clin Pharmacol Ther. 2001;69:238–244. doi: 10.1067/mcp.2001.114670. [DOI] [PubMed] [Google Scholar]
  • 24.Celik T, Yuksel UC, Iyisoy A. Effects of nebivolol on platelet activation in hypertensive patients: A comparative study with metoprolol. Int J Cardiol. 2007;116:206–211. doi: 10.1016/j.ijcard.2006.03.046. [DOI] [PubMed] [Google Scholar]
  • 25.Wolf SC, Sauter G, Preyer M. Influence of nebivolol and metoprolol on inflammatory mediators in human coronary endothelial or smooth muscle cells. Effects on neointima formation after balloon denudation in carotid arteries of rats treated with nebivolol. Cell Physiol Biochem. 2007;19:129–136. doi: 10.1159/000099201. [DOI] [PubMed] [Google Scholar]
  • 26.Hammond DC, Brooksher RD, Mann RJ, Beernink JH. The dorsal skin-flap model in the rat: Factors influencing survival. Plast Reconstr Surg. 1993;91:316–321. doi: 10.1097/00006534-199302000-00017. [DOI] [PubMed] [Google Scholar]
  • 27.Parlakpinar H, Ozer MK, Sahna E. Amikacin-induced acute renal injury in rats: Protective role of melatonin. J Pineal Res. 2003;35:85–90. doi: 10.1034/j.1600-079x.2003.00059.x. [DOI] [PubMed] [Google Scholar]
  • 28.Sahna E, Parlakpinar H, Ozturk F. The protective effects of physiological and pharmacological concentrations of melatonin on renal ischemia-reperfusion injury in rats. Urol Res. 2003;31:188–193. doi: 10.1007/s00240-003-0314-5. [DOI] [PubMed] [Google Scholar]
  • 29.Podczasy JJ, Wei R. Reduction of iodonitrotetrazolium violet by superoxide radicals. Biochem Biophys Res Commun. 1988;150:1294–1301. doi: 10.1016/0006-291x(88)90770-x. [DOI] [PubMed] [Google Scholar]
  • 30.Carvalho EN, Ferreira LM, Carvalho NA. Viability of a random pattern dorsal skin flap, in diabetic rats. Acta Cir Bras. 2005;20:225–228. doi: 10.1590/s0102-86502005000300006. [DOI] [PubMed] [Google Scholar]
  • 31.Askar I, Bozkurt M. Protective effects of immunosuppressants and steroids against ischemia-reperfusion injury in cremaster muscle flap at microcirculatory level. Microsurgery. 2002;22:361–366. doi: 10.1002/micr.10071. [DOI] [PubMed] [Google Scholar]
  • 32.Davies BW, Lewis RD, Pennington G. The impact of vasodilators on random-pattern skin flap survival in the rat following mainstream smoke exposure. Ann Plast Surg. 1998;40:630–636. doi: 10.1097/00000637-199806000-00010. [DOI] [PubMed] [Google Scholar]
  • 33.Puckett CL, Misholy H, Reinisch JF. The effects of streptokinase on ischemic flaps. J Hand Surg [Am] 1983;8:101–104. doi: 10.1016/s0363-5023(83)80066-5. [DOI] [PubMed] [Google Scholar]
  • 34.Im MJ, Manson PN, Bulkley GB, Hoopes JE. Effects of superoxide dismutase and allopurinol on the survival of acute island skin flaps. Ann Surg. 1985;201:357–359. doi: 10.1097/00000658-198503000-00018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Bilgin-Karabulut A, Ademoglŭ E, Aydin I. Protective effects of vitamins A and E pretreatment in venous ischemia/reperfusion injury. J Reconstr Microsurg. 2001;17:425–429. doi: 10.1055/s-2001-16356. [DOI] [PubMed] [Google Scholar]
  • 36.Sagi A, Ferder M, Levens D, Strauch B. Improved survival of island flaps after prolonged ischemia by perfusion with superoxide dismutase. Plast Reconstr Surg. 1986;77:639–644. doi: 10.1097/00006534-198604000-00022. [DOI] [PubMed] [Google Scholar]
  • 37.Im MJ, Hoopes JE, Yoshimura Y. Xanthine:acceptor oxidoreductase activities in ischemic rat skin flaps. J Surg Res. 1989;46:230–234. doi: 10.1016/0022-4804(89)90062-0. [DOI] [PubMed] [Google Scholar]
  • 38.Gurlek A, Aydogan H, Parlakpinar H. Protective effect of melatonin on random pattern skin flap necrosis in pinealectomized rat. J Pineal Res. 2004;36:58–63. doi: 10.1046/j.1600-079x.2003.00099.x. [DOI] [PubMed] [Google Scholar]

Articles from Current Therapeutic Research, Clinical and Experimental are provided here courtesy of Elsevier

RESOURCES